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Abstract
Background: The methodological quality of animal studies is an important factor hampering the translation of results from
animal studies to a clinical setting. Systematic reviews of animal studies may provide a suitable method to assess and
thereby improve their methodological quality.
Objectives: The aims of this study were: 1) to evaluate the risk of bias assessment in animal-based systematic reviews, and
2) to study the internal validity of the primary animal studies included in these systematic reviews.
Data Sources: We systematically searched Pubmed and Embase for SRs of preclinical animal studies published between
2005 and 2012.
Results: A total of 91 systematic reviews met our inclusion criteria. The risk of bias was assessed in 48 (52.7%) of these 91
systematic reviews. Thirty-three (36.3%) SRs provided sufficient information to evaluate the internal validity of the included
studies. Of the evaluated primary studies, 24.6% was randomized, 14.6% reported blinding of the investigator/caretaker,
23.9% blinded the outcome assessment, and 23.1% reported drop-outs.
Conclusions: To improve the translation of animal data to clinical practice, systematic reviews of animal studies are
worthwhile, but the internal validity of primary animal studies needs to be improved. Furthermore, risk of bias should be
assessed by systematic reviews of animal studies to provide insight into the reliability of the available evidence.
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Introduction
The majority of animal experiments is being carried out in the
context of preclinical research, e.g. to test safety and efficacy of
new treatments to improve healthcare. However, translating
animal data to the human situation has been proven to be very
challenging. Various factors influence this translation, such as
biological differences between species, internal validity, differences
in experimental design between animal studies and clinical trials,
insufficient reporting, and publication bias [1]. Systematic reviews
(SRs) of animal studies have the potential to reduce some of the
challenges in the translation of animal data to clinical trials, for
example by explicitly assessing the internal validity. SRs attempt to
identify, appraise and synthesize all the empirical evidence that
meets pre-specified eligibility criteria to answer a given research
question. SRs of animal studies are still quite rare, but their
number appears to be slightly increasing [2–4].However, little is
known about the extent to which the available SRs include a risk
of bias assessment, in which the internal validity of the included
primary animal studies is evaluated. We therefore performed a
systematic review of the risk of bias assessment in SRs of animal
studies. Subsequently, we studied the internal validity of the
individual studies included in these SRs.
Materials and Methods
Search Strategy
To find all SRs of animal studies published between 2005 and
2012, the following search strategy was carried out on 28 January
2013. To identify animal studies, the MEDLINE (PubMed
platform) and EMBASE (OvidSP platform) databases were
searched using the ‘Animal’ filter for PubMed by Hooijmans
et al., [5] and the filter for EMBASE by De Vries et al., [6,7]
respectively. Since we were interested in SRs, we used the clinical
query for SRs from PubMed, which we have adapted for Embase
(see S1).
Study Selection
For the purpose of this study, a review was classified as a SR
when at least all of the following items were reported: 1) the term
Systematic Review 2) database(s) searched and 3) search terms.
Selection was performed by two independent observers and
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disagreements were resolved through discussion (JvL, BB, ML).
Only SRs aiming to inform human healthcare by reviewing a
medical drug intervention were included, such as vitamin-based
supplementations or stem cells treatment. Medical devices, such as
prosthetics and scaffolds, and other types of interventions such as
oxygen or heat were excluded. We also excluded SRs that were
not written in English or could not be retrieved in full text. When
supplementary data were available online, these were obtained.
Scoring Procedure of SRs
Data on both the characteristics and methods used to assess risk
of bias in the SRs were extracted by at least two independent
reviewers (JvL, BB, ML). In SRs where both animal and human
studies were included in the SR, only the animal data were
evaluated. Disagreements between reviewers were resolved
through discussion and if necessary a third reviewer was consulted.
Assessment risk of bias items. The methodology of quality
assessment differs between SRs of animal studies [8]. For the
purpose of this study we focused on the internal validity of primary
studies. Therefore, we defined quality assessment as a risk of bias
assessment. To fit this definition, the assessment had to include at
least one of the following internal validity items: 1) randomized
study design (selection bias), 2) blinding of investigator/caretaker
(performance bias), 3) blinding of outcome assessment (detection
bias) and 4) mentioning of drop-outs (attrition bias).
SR characteristics. Additional information on the charac-
teristics of the SRs was extracted: 1) the way in which the risk of
bias was taken into account in the SR (e.g. conduct of subgroup
analyses based on quality, exclusion of studies based on quality or
a general comment/statement related to the study quality), 2) level
of reporting detail on internal validity (e.g. score per item or a
summary for quality per study) and 3) research area of the SR.
Data Extraction Primary Studies
SRs that provided detailed information on the required internal
validity items were used to evaluate the internal validity of the
included individual studies. Per SR, data were extracted on: total
number of included studies and number of studies per item
(randomised study design, blinding investigator/caretaker, blind-
ing outcome assessment and drop-outs).
Results
Literature Search and SR Selection
We identified 592 potentially eligible articles, of which 91 SRs
met our inclusion criteria. Figure 1 shows the number of studies
identified at each stage of the selection process. A complete list of
the 91 references can be found elsewhere (see Table S1 in File S2).
Characteristics of Included Systematic Reviews
The number of published systematic reviews of animal studies
increased over the last years from 6 in 2005 and 2, 6 and 12 in
2006, 2008 and 2010 to 32 in 2012, respectively (Figure 2).
The 91 SRs included in this review cover a range of research
topics. Most reviews (n = 38; 41.8%) cover a neurological topic, of
which 20 reviews (22.0%) pertained to stroke. The second largest
group was on endocrinology (n = 11; 12.1%). Other topics
included cardiovascular diseases, orthopaedics, infectious diseases,
oncology, pharmacotoxicology, dentistry and gastroenterology.
The complete list of topics and number of SRs per topic can also
be found elsewhere (see Table S1 in File S2).
Risk of Bias Assessment
Risk of bias assessment in systematic reviews. Nearly
half of the SRs (n= 43; 47.3%) did not assess any of the risk of bias
items (figure 3). In 48 reviews (52.7%), one or more of our
predefined risk of bias items were assessed. Thirty-three (36.3%)
reviews also provided detailed information on the outcome of this
assessment per individual study.
Figure 3 shows that of the 91 SRs only 3 (3.3%) assessed all 4
internal validity items in their quality assessment. Twenty-two SRs
(24.2%) assessed 3 items, of which 17 SRs (18.7%) did not assess
drop-outs; the other 5 (5.5%) did not score blinding of the
caretaker. Fourteen SRs (15.4%) assessed two items namely
randomisation and blinding (of these, 13 SRs assessed blinding of
the outcome assessment, in one SR the type of blinding was
unclear). Nine SRs (9.9%) assessed only one item, which in all
cases was randomisation.
Risk of bias use in SRs. Of the 48 SRs that assessed risk of
bias of included individual studies, 45 (93.8%) referred to the
internal validity of the primary studies in the results, discussion or
conclusion section. This means that three SRs did not discuss the
outcome of the risk of bias assessment in any way. In most reviews,
(n = 42; 87.5%) a general comment was made on the quality of the
primary studies. In 25 SRs (52.1%), the primary study quality was
used as a factor in the meta-analysis (e.g. subgroup analyses) and in
three SRs the study quality was used as an exclusion criterion (see
Table S1 in File S2).
Internal Validity of Primary Studies
Thirty-three SRs that provided detailed information on the risk
of bias assessment were used to evaluate the internal validity of the
included primary studies. These 33 SRs included a total of 2280
primary studies (median 18, range: 2 – 1152 primary studies).
Most of these studies were on the subject of stroke or other
neurological topics (see Table S1 and S2 in File S2).
Figure 4 provides an overview of risk of bias scores of the
individual animal studies per item (randomisation, blinding of
caretaker/investigator, blinding of outcome assessment and drop-
outs). As not all reviews scored all four items we evaluated (see
figure 3), the number of primary studies varies per item in figure 4.
Of the 2280 included primary studies, 562 (24.6%) were
randomised. Blinding of the investigator/caretaker was scored
for 546 (23.9%) primary studies, of which 80 (14.6%) were actually
blinded. Blinding of the outcome assessment was scored for 2220
(97.4%) primary studies, of which 530 (23.9%) were indeed
blinded. Drop-outs were scored in only 78 (3.4%) primary studies,
of which 18 (23.1%) really did reported drop-outs. One study
assessed blinding, without specifying the type of blinding.
Therefore, the data of this study were not included in our results
(see Table S1 and S2 in File S2).
Discussion
Our results show that the assessment of the methodological
quality by systematic reviews of animal studies is quite poor. Half
of the 91 evaluated SRs did not critically appraise the risk of bias
in the included studies. Furthermore, the thirty-three reviews that
did assess and report the risk of bias showed that the internal
validity of most individual animal studies is poor as well.
Therefore, there is a real risk that the outcomes of both, the
individual studies and the subsequent SRs of these studies are
biased.
Our findings that the methodological quality of SRs is poor are
in line with findings by Peters et al., who identified a number of
deficiencies in the conduct and reporting of SRs and meta-analyses
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of animal studies. Peters et al. suggest that initiatives to improve
the conduct and reporting of primary animal studies and of SRs of
animal studies should go hand-in-hand [2]. Poor internal validity
of animal studies has previously been demonstrated by Kilkenny
Figure 1. Flow diagram the systematic review literature search results. A total of 91 systematic reviews of intervention animal studies were
included.
doi:10.1371/journal.pone.0089981.g001
Figure 2. Number (n) of published SRs of intervention animal
studies per publication year (2005–2012).
doi:10.1371/journal.pone.0089981.g002
Figure 3. Percentages of SRs per number of internal validity
item scored. Zero items by 47.3%, one item all randomisation, two
items randomisation and one level of blinding, three items randomisa-
tion, blinding of caretaker/investigator and blinding of outcome
assessment or randomisation, one level of blinding and drop-outs)
and all four items by 3.3%.
doi:10.1371/journal.pone.0089981.g003
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et al. Of the 271 publications of animal studies they surveyed, only
13% had been randomised and 14% had blinded the outcome
assessment [9]. We found slightly higher percentages, namely
24.6% randomisation and 23.9% for blinding. These higher
percentages may be explained by two factors. First, our study
contains a relative high number of stroke studies. Over the last
decades, researchers in the field of stroke have been actively
working on recommendations and guidelines for preclinical
research in order to improve effective translation [10]. Second,
over the last years, general awareness of the need for better
reporting of animal studies has been steadily increasing.
Although both the methodological quality of animal SRs and
the internal validity of primary animal studies have been
investigated before, they were studied separately by different
research groups and more recent SRs of animal studies have not
yet been taken into account. A major strength of our study is,
therefore, that by updating and combining these evaluations in
one study, we were able to gain more in-depth insight into the
current state and level of available preclinical evidence.
Some potential limitations should also be discussed. First, we
have restricted ourselves to one type of SR, namely SRs of animal-
based drug-intervention studies, which might hamper the gener-
alization of our results to other SRs of animal studies. Although we
excluded SRs of animal studies that are not directly related to
clinical research, we consider it likely that the latter type of SRs are
of lower methodological quality, as the SR methodology and
measures to safeguard internal validity may not be as well
established as in fields closely related to clinical research.
Therefore, our restriction might have caused an overestimation
of the methodological quality of SRs and the internal validity of
primary studies in general. Second, it cannot be ruled out that a
small proportion of the SRs did not assess certain internal validity
items, because the experimental design of the included individual
studies did not allow a risk of bias assessment (e.g. due to a lack of
(independent) control groups). Third, some individual studies may
have been less subject to bias than the SRs estimated due to a lack
of (adequate) reporting of the randomization and/or blinding
methods they actually used. Fourth, we have not investigated
whether the SRs assessed the adequacy of the method of
randomisation or blinding. Inadequate randomization and blind-
ing in animal studies can cause overestimation of the effect size
[11,12] and thus may falsely inform other preclinical research or
clinical trials. In principle, this means that even randomised studies
could be subject to bias, namely when the randomisation method
was not adequate for the study design. Similarly, some SRs
assessed blinding but did not specify the level or type of blinding.
As long as the reporting of animal studies remains poor, however,
these limitations are hardly avoidable.
Adequate internal validity of animal studies has been described
as one of the key factors for improving the translation of results to
human studies [1]. SRs can be a useful method to evaluate and
analyse (the quality of) available evidence. As previously stated,
SRs of animal studies could profit from the use of guidelines [2].
Currently, there is no standard procedure available for conducting
SRs of animal studies [8,13]. This could be one of the reasons why
so many animal-based SRs did not assess any of the risk of bias
items. Valuable lessons can be learned here from the guidelines
used in clinical research, such as the CONSORT and PRISMA
statements. Guidelines for planning, conducting and reporting
primary animal studies are already available [14,15]. Even though
the ARRIVE guidelines are adopted by many journals, the effect
on publication standards of animal studies is still very minimal.
Therefore, effective implementation of endorsement of these
guidelines requires more attention [16]. As does education on this
matter. A good education strategy regarding both the internal
validity of animal studies and the SR methodology can help raise
awareness for the current state of potentially biased animal data.
Authors, as well as reviewers and editors, need to be aware of the
potential risk of this bias in animal studies and how it can
adequately be reduced to eventually produce high-quality research
with reliable results for human healthcare.
Conclusions
To improve the translation of animal data to clinical practice,
systematic reviews of animal studies are worthwhile, but the
internal validity of the individual animal studies needs to be
improved. Furthermore, risk of bias should be assessed by SRs of
animal studies to provide insight into the reliability of available
evidence.
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